ACOG Straddle Strategy
ACOG (Alpha Cognition Inc), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
ACOG (Alpha Cognition Inc) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $139.0M, a beta of 2.23 versus the broader market, a 52-week range of 4.5-10, average daily share volume of 63K, a public-listing history dating back to 2024, approximately 71 full-time employees. These structural characteristics shape how ACOG stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 2.23 indicates ACOG has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a straddle on ACOG?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
ACOG snapshot
As of August 14, 2026, spot at $8.77, ATM IV 187.40%, expected move 53.73%. The straddle on ACOG below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this straddle structure on ACOG specifically: IV rank is unavailable in the current snapshot, so regime-based timing for ACOG is inferred from ATM IV at 187.40% alone, with a market-implied 1-standard-deviation move of approximately 53.73% (roughly $4.71 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ACOG expiries trade a higher absolute premium for lower per-day decay. Position sizing on ACOG should anchor to the underlying notional of $8.77 per share and to the trader's directional view on ACOG stock.
ACOG straddle setup
The ACOG straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ACOG at $8.77 on that close, the first option leg uses a $8.77 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ACOG chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ACOG shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $8.77 | N/A |
| Buy 1 | Put | $8.77 | N/A |
ACOG straddle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
ACOG straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on ACOG. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use straddle on ACOG
Straddles on ACOG are pure-volatility plays that profit from large moves in either direction; traders typically buy ACOG straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
ACOG thesis for this straddle
The market-implied 1-standard-deviation range for ACOG extends from approximately $4.06 on the downside to $13.48 on the upside. A ACOG long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. As a Healthcare name, ACOG options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ACOG-specific events.
ACOG straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ACOG positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ACOG alongside the broader basket even when ACOG-specific fundamentals are unchanged. Always rebuild the position from current ACOG chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on ACOG?
- A straddle on ACOG is the straddle strategy applied to ACOG (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With ACOG stock at $8.77 on the most recent close, the strikes shown on this page are snapped to the nearest listed ACOG chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are ACOG straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the ACOG straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 187.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ACOG straddle?
- The breakeven for the ACOG straddle priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The ACOG market-implied 1-standard-deviation expected move in the same options snapshot is approximately 53.73%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on ACOG?
- Straddles on ACOG are pure-volatility plays that profit from large moves in either direction; traders typically buy ACOG straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current ACOG implied volatility affect this straddle?
- Current ACOG ATM IV is 187.40%; IV rank context is unavailable in the current snapshot.